Waters (WAT) reported earnings 30 days ago. What's next for the stock?
Waters Corporation ( WAT ) Jefferies London Healthcare Conference 2025 November 18, 2025 9:30 AM EST Company Participants Udit Batra - President, CEO & Director Conference Call Participants Tycho Peterson - Jefferies LLC, Research Division Presentation Tycho Peterson Jefferies LLC, Research Division Okay. Thank you, everybody.
WAT posts strong Q3 results with 16% earnings growth and higher sales, lifting its full-year outlook for 2025.
Waters Corporation ( WAT ) Q3 2025 Earnings Call November 4, 2025 8:00 AM EST Company Participants Caspar Tudor - Head of Investor Relations Udit Batra - President, CEO & Director Amol Chaubal - Senior VP & CFO Conference Call Participants Tycho Peterson - Jefferies LLC, Research Division Jack Meehan - Nephron Research LLC Puneet Souda - Leerink Partners LLC, Research Division Casey Woodring - JPMorgan Chase & Co, Research Division Douglas Schenkel - Wolfe Research, LLC Daniel Arias - Stifel, Nicolaus & Company, Incorporated, Research Division Catherine Ramsey - Robert W. Baird & Co. Incorporated, Research Division Brandon Couillard - Wells Fargo Securities, LLC, Research Division Presentation Operator Welcome to the Waters Corporation's Third Quarter 2025 Financial Results Conference Call.
Waters (WAT) came out with quarterly earnings of $3.4 per share, beating the Zacks Consensus Estimate of $3.21 per share. This compares to earnings of $2.93 per share a year ago.
Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Waters Corporation (NYSE:WAT ) Q2 2025 Earnings Conference Call August 4, 2025 8:00 AM ET Company Participants Amol Chaubal - Senior VP & CFO Caspar Tudor - Head of Investor Relations Udit Batra - President, CEO & Director Conference Call Participants Catherine Walden Ramsey Schulte - Robert W. Baird & Co. Incorporated, Research Division Daniel Gregory Brennan - TD Cowen, Research Division Jack Meehan - Nephron Research LLC Puneet Souda - Leerink Partners LLC, Research Division Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division Sung Ji Nam - Scotiabank Global Banking and Markets, Research Division Tycho W.
Waters (WAT) came out with quarterly earnings of $2.95 per share, beating the Zacks Consensus Estimate of $2.93 per share. This compares to earnings of $2.63 per share a year ago.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Waters (WAT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Waters Corp (NYSE:WAT) shares fell more than 12% after it announced a business combination deal with BD Biosciences & Diagnostic Solutions (NYSE:BDX), forming a new life sciences and diagnostics leader focused on high-volume, regulated testing markets. The transaction, structured as a Reverse Morris Trust and valued at approximately $17.5 billion, is expected to significantly expand Waters' market reach and strengthen its position in key adjacent sectors.